CompletedNot Applicable

Complications After Endoscopic Retrograde Cholangiopancreatography

500 participantsStarted 2017-01-01

Plain-language summary

Retrospective study to analyze benign complications and malignancy risks after ERCP with sphincterotomy. All patients who received a ERCP with sphincterotomy for a benign disease will be included. Post-ERCP hepato-biliary complications in the follow-up will be registered.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients having undergone ERCP with sphincterotomy for benign diseases between 1995 and 2015 Exclusion Criteria: * Diagnosis of primary malignant tumors in the liver, bile ducts including ampullary region, and pancreas in the ERCP test. * Patients with follow-up less than two years after the ERCP and biliopancreatic malignancy diagnostic in this period.

What they're measuring

long-term complications after ERCP with sphincterotomy

Timeframe: 10 years

Trial details

NCT IDNCT04735224

SponsorJuan Carlos Martín del Olmo

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-10-10

View on ClinicalTrials.gov More Choledocholithiasis With Acute Cholangitis (Diagnosis) trials